📂 Drugs
Empagliflozin/linagliptin/metformin — Definition
Empagliflozin/linagliptin/metformin / Empagliflozin/linagliptin/metformin
Type 2 is a triple combination drug used in diabetes treatment. Empagliflozin is an SGLT2 inhibitor that reduces blood sugar by increasing glucose excretion from the kidneys. Linagliptin is a DPP-4 inhibitor that regulates insulin release by increasing inkretin hormones. Metformin is the first step antidiabetic agent that reduces glucose production in the liver and acts by increasing insulin sensitivity.
Frequently Asked Questions
❓ What is Empagliflozin/linagliptin/metformin?
Empagliflozin/linagliptin/metformin; type 2 is a triple combination drug used in diabetes treatment. Empagliflozin is an SGLT2 inhibitor that reduces blood sugar by increasing glucose excretion from the kidneys. Linagliptin is a DPP-4 inhibitor that regulates insulin release by increasing inkretin hormones. Metformin is the first step antidiabetic agent that reduces glucose production in the liver and acts by increasing insulin sensitivity.
❓ What is Empagliflozin/linagliptin/metformin in Turkish?
The Turkish equivalent of "Empagliflozin/linagliptin/metformin" is Empagliflozin/linagliptin/metformin.
❓ Which medical field is Empagliflozin/linagliptin/metformin related to?
This term belongs to the Drugs category.